Predicting In Vivo Behavior of injectable, In Situ-forming drug-delivery Systems

References

• Mitra A Wu Y . Use of in vitro–in vivo correlation (IVIVC) to facilitate the development of polymer-based controlled release injectable formulations. Recent Pat. Drug Deliv. Formul.4 (2), 94–104 (2010).
   PubMedGoogle Scholar
• Shen J Burgess DJ . In vitro–in vivo correlation for complex non-oral drug products: where do we stand?J. Control. Rel.219, 644–651 (2015).
   PubMed Web of Science ®Google Scholar
• Owen A Rannard S . Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: insights for applications in HIV therapy. Adv. Drug Deliv. Rev. (2016).
   PubMed Web of Science ®Google Scholar
• Packhaeuser CB Schnieders J Oster CG Kissel T . In situ forming parenteral drug-delivery systems: an overview. Eur. J. Pharm. Biopharm.58 (2), 445–455 (2004).
   PubMed Web of Science ®Google Scholar
• Dunn RL English JP Cowsar DR Vanderbilt DP . Biodegradable in-situ forming implants and methods of producing the same. (1990).
   Google Scholar
• Berges R Bello U . Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancer. Curr. Med. Res. Opin.22 (4), 649–655 (2006).
   PubMed Web of Science ®Google Scholar
• Schulman C Alcaraz A Berges R Montorsi F Teillac P Tombal B . Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer. BJU Int.100 (Suppl. 1), 1–5 (2007).
   PubMed Web of Science ®Google Scholar
• Mchugh AJ . The role of polymer membrane formation in sustained release drug-delivery systems. J. Control. Rel.109 (1–3), 211–221 (2005).
   PubMed Web of Science ®Google Scholar
• Larsen C Larsen SW Jensen H Yaghmur A Østergaard J . Role of in vitro release models in formulation development and quality control of parenteral depots. Exp. Opin. Drug Deliv.6 (12), 1283–1295 (2009).
   PubMed Web of Science ®Google Scholar
• Solorio L Exner AA . Effect of the subcutaneous environment on phase-sensitive in situ-forming implant drug release, degradation, and microstructure. J. Pharm. Sci.104 (12), 4322–4328 (2015).
   PubMed Web of Science ®Google Scholar
• Kempe S Mader K . In situ forming implants–an attractive formulation principle for parenteral depot formulations. J. Control. Rel.161 (2), 668–679 (2012).
   PubMed Web of Science ®Google Scholar
• Graham PD Brodbeck KJ Mchugh AJ . Phase inversion dynamics of PLGA solutions related to drug delivery. J. Control. Rel.58 (2), 233–245 (1999).
   PubMed Web of Science ®Google Scholar
• Solorio L Sundarapandiyan D Olear A Exner AA . The effect of additives on the behavior of phase sensitive in situ forming implants. J. Pharm. Sci.104 (10), 3471–3480 (2015).
   PubMed Web of Science ®Google Scholar
• Brodbeck KJ Desnoyer JR Mchugh AJ . Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J. Control. Rel.62 (3), 333–344 (1999).
   PubMed Web of Science ®Google Scholar
• Burgess DJ Hussain AS Ingallinera TS Chen ML . Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP. Pharm. Res.19 (11), 1761–1768 (2002).
   PubMedGoogle Scholar
• Hatefi A Amsden B . Biodegradable injectable in situ forming drug-delivery systems. J. Control. Rel.80 (1), 9–28 (2002).
   PubMed Web of Science ®Google Scholar
• Manaspon C Nittayacharn P Vejjasilpa K Fongsuk C Nasongkla N . SN-38: β-cyclodextrin inclusion complex for in situ solidifying injectable polymer implants. Presented at : Engineering in Medicine and Biology Society, EMBC, 2011 Annual International Conference of the IEEE. 3241–3244 (2011).
   Google Scholar
• Do MP Neut C Metz H et al. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance. Int. J. Pharm.486 (1–2), 38–51 (2015).
   PubMedGoogle Scholar
• Solorio L Patel RB Wu H Krupka T Exner AA . Advances in image-guided intratumoral drug delivery techniques. Ther. Deliv.1 (2), 307–322 (2010).
   PubMedGoogle Scholar
• Patel RB Carlson AN Solorio L Exner AA . Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug-delivery systems. J. Biomed. Mater. Res. A94 (2), 476–484 (2010).
   PubMedGoogle Scholar
• Beyer S Xie L Schmidt M et al. Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniques. J. Control. Rel.235, 352–364 (2016).
   PubMed Web of Science ®Google Scholar
• Hernandez C Gawlik N Goss M et al. Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants. J. Control. Rel.243, 225–231 (2016).
   PubMed Web of Science ®Google Scholar
• Solorio L Olear AM Hamilton JI et al. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging. Theranostics2 (11), 1064–1077 (2012).
   PubMed Web of Science ®Google Scholar
• Zhou HY Gawlik A Hernandez C Goss M Mansour J Exner A . Nondestructive characterization of biodegradable polymer erosion in vivo using ultrasound elastography imaging. ACS Biomater. Sci. Eng.2 (6), 1005–1012 (2016).
   PubMed Web of Science ®Google Scholar
• Kim K Wagner WR . Non-invasive and non-destructive characterization of tissue engineered constructs using ultrasound imaging technologies: a review. Ann. Biomed. Eng.44 (3), 621–635 (2016).
   PubMed Web of Science ®Google Scholar
• Dalecki D Mercado KP Hocking DC . Quantitative ultrasound for nondestructive characterization of engineered tissues and biomaterials. Ann. Biomed. Eng.44 (3), 636–648 (2016).
   PubMed Web of Science ®Google Scholar
• Zhou J Hu W Tang L . Non-invasive characterization of immune responses to biomedical implants. Ann. Biomed. Eng.44 (3), 693–704 (2016).
   PubMed Web of Science ®Google Scholar
• Kim W Ferguson VL Borden M Neu CP . Application of elastography for the noninvasive assessment of biomechanics in engineered biomaterials and tissues. Ann. Biomed. Eng.44 (3), 705–724 (2016).
   PubMed Web of Science ®Google Scholar
• Parent M Nouvel C Koerber M Sapin A Maincent P Boudier A . PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. J. Control. Rel.172 (1), 292–304 (2013).
   PubMed Web of Science ®Google Scholar
• Hulsart-Billstrom G Dawson J Hofmann S et al. A surprisingly poor correlation between in vitro and in vivo testing of biomaterials for bone regeneration: results of a multicentre analysis. Eur. Cell. Mater.31, 312–322 (2016).
   PubMed Web of Science ®Google Scholar